Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

GGO-dominant PPLs Diagnosis Using CLE and ssRAB-guided Cryobiopsy

NCT06910046 · Shanghai Chest Hospital · Updated 6 April 2025

What is being tested
CLE and ssRAB-guided cryobiopsy
For
Lung Ground-Glass Opacity
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 119 people. The full rules are on the registry page.
Where
China
When
Starts or started April 2025, ends April 2027. Registered 4 April 2025.
Results
None posted yet.

In the researchers' words

The purpose of the study is to evaluate the diagnostic performance and safety of cryobiopsy for ground-glass opacity (GGO)-dominant peripheral pulmonary lesions (PPLs) under the guidance of shape-sensing robotic-assisted bronchoscopy (ssRAB) combined with confocal laser endomicroscopy (CLE). Additionally, the study aims to establish CLE interpretation criteria for GGO-dominant PPLs based on histopathological characteristics and validate the proposed criteria.
ClinicalTrials.gov, NCT06910046

Sites

  • Shanghai Chest HospitalShanghai, Shanghai Municipality, China